1. Home
  2. BWXT vs BMRN Comparison

BWXT vs BMRN Comparison

Compare BWXT & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWXT
  • BMRN
  • Stock Information
  • Founded
  • BWXT 1867
  • BMRN 1996
  • Country
  • BWXT United States
  • BMRN United States
  • Employees
  • BWXT N/A
  • BMRN N/A
  • Industry
  • BWXT
  • BMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BWXT
  • BMRN Health Care
  • Exchange
  • BWXT Nasdaq
  • BMRN Nasdaq
  • Market Cap
  • BWXT 12.8B
  • BMRN 12.1B
  • IPO Year
  • BWXT N/A
  • BMRN 1999
  • Fundamental
  • Price
  • BWXT $137.04
  • BMRN $58.00
  • Analyst Decision
  • BWXT Buy
  • BMRN Buy
  • Analyst Count
  • BWXT 9
  • BMRN 22
  • Target Price
  • BWXT $138.83
  • BMRN $93.43
  • AVG Volume (30 Days)
  • BWXT 1.4M
  • BMRN 2.1M
  • Earning Date
  • BWXT 08-04-2025
  • BMRN 08-04-2025
  • Dividend Yield
  • BWXT 0.73%
  • BMRN N/A
  • EPS Growth
  • BWXT 13.77
  • BMRN 152.82
  • EPS
  • BWXT 3.14
  • BMRN 2.71
  • Revenue
  • BWXT $2,781,946,000.00
  • BMRN $2,950,227,000.00
  • Revenue This Year
  • BWXT $15.44
  • BMRN $12.23
  • Revenue Next Year
  • BWXT $9.29
  • BMRN $9.99
  • P/E Ratio
  • BWXT $43.65
  • BMRN $21.48
  • Revenue Growth
  • BWXT 9.88
  • BMRN 19.36
  • 52 Week Low
  • BWXT $84.21
  • BMRN $52.93
  • 52 Week High
  • BWXT $145.33
  • BMRN $94.85
  • Technical
  • Relative Strength Index (RSI)
  • BWXT 53.14
  • BMRN 59.75
  • Support Level
  • BWXT $133.84
  • BMRN $56.76
  • Resistance Level
  • BWXT $144.58
  • BMRN $59.98
  • Average True Range (ATR)
  • BWXT 3.38
  • BMRN 1.44
  • MACD
  • BWXT -1.66
  • BMRN 0.62
  • Stochastic Oscillator
  • BWXT 29.33
  • BMRN 81.47

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales primarily in the United States, Canada, and other regions.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

Share on Social Networks: